Group 1 - The core viewpoint of the article is that Renhe Pharmaceutical has entered into a strategic cooperation agreement with Huajian Medical to explore new models of asset digitization, capitalization, and globalization operations based on blockchain technology in the OTC intellectual property RWA field [1] - The agreement is described as a comprehensive, long-term, and strategic partnership between the two companies [1] - The company clarifies that this agreement does not constitute a significant contract that requires public announcement under relevant regulations and does not have a major impact on the company's current performance [1]

Group 1 - The core viewpoint of the news is that Huajian Medical and Renhe Pharmaceutical have established a strategic partnership to create the world's first specialized trading platform for Real World Assets (RWA) in the over-the-counter (OTC) drug sector [1][2] - The platform will adhere to securities-level standards and aims to provide an efficient, transparent, and compliant digital trading venue for intangible assets such as intellectual property, future revenue rights, and brand value in the OTC industry [1][2] - Renhe Pharmaceutical, as the president unit of the China OTC Association, plays a significant role in industry policy discussions and standard-setting, leveraging its competitive position in the Chinese OTC market to lead industry development [1][2] Group 2 - This strategic cooperation marks a new phase for the "ETHK" blockchain financial ecosystem strategy, showcasing the innovative "ETHK Global RWA Trading Exchange" business model on a global stage [2] - The collaboration reflects the company's commitment to creating a truly open and empowering digital financial ecosystem through cutting-edge technology and rigorous compliance practices [2] - The ultimate mission of financial technology is to serve the real economy and create inclusive value, with the partnership exemplifying this belief [2] Group 3 - The board believes that this strong alliance will generate significant synergies, positively impacting the strategic transformation and value reassessment of both companies [3] - The collaboration aims to ensure the successful launch and stable operation of the world's first OTC RWA exchange by pooling the strengths and resources of both parties [3] - The partnership is expected to inject strong momentum into the sustainable business growth and financial performance of the group [3]

Core Viewpoint - Huajian Medical (01931) has announced a strategic partnership with Renhe Pharmaceutical (000650.SZ) to establish the world's first vertical RWA exchange focused on the OTC sector in the United States, marking a significant step in the implementation of its "ETHK blockchain financial ecosystem strategy" [1][2] Group 1: Strategic Collaboration - The collaboration with Renhe Pharmaceutical signifies a new phase in the large-scale implementation and value realization of the "ETHK" blockchain financial ecosystem strategy [1] - This partnership serves as a benchmark case for the innovative "ETHK global RWA exchange" business model, aiming to create a replicable model that validates the feasibility and potential of this innovation [1] Group 2: Vision and Mission - The company believes that the ultimate mission of financial technology is to serve the real economy and create inclusive value, which this collaboration exemplifies [2] - The goal is to empower classic national brands like Renhe Pharmaceutical to achieve digital transformation and promote successful ecological models across various industries, contributing to national industrial upgrades and the development of the digital economy [2] Group 3: Future Outlook - The board is confident that this strong alliance will generate significant synergies, positively impacting the strategic transformation and value reassessment of both companies [2] - The company aims to ensure the successful launch and stable operation of the world's first OTC RWA exchange through close collaboration with Renhe Pharmaceutical, leveraging both parties' resources [2]

Group 1 - The core viewpoint of the news is that Huajian Medical and Renhe Pharmaceutical have established a strategic partnership to create the world's first specialized trading platform for over-the-counter (OTC) real-world assets (RWA) [1][2] - The platform will adhere to securities-level standards and aims to provide an efficient, transparent, and compliant digital trading venue for intangible assets and product rights in the OTC industry, addressing a critical gap in the global market [1][2] - Renhe Pharmaceutical, as the president unit of the China OTC Association, plays a significant role in industry policy discussions and standard-setting, leveraging its competitive position in the Chinese OTC market to lead industry development [1] Group 2 - This strategic cooperation marks a new phase for the "ETHK" blockchain financial ecosystem strategy, showcasing the innovative "ETHK global RWA trading platform" model on a global stage [2] - The collaboration reflects the company's commitment to using cutting-edge technology and rigorous compliance practices to build an open and empowering digital financial ecosystem [2] - The partnership aims to facilitate the digital transformation of classic national brands like Renhe Pharmaceutical, contributing to national industrial upgrades and the development of the digital economy [2] Group 3 - The board believes that this collaboration will generate significant synergies, positively impacting the strategic transformation and value reassessment of both companies [3] - The companies will work closely to ensure the successful launch and stable operation of the world's first OTC RWA trading platform, leveraging their combined resources [3]

Core Viewpoint - The strategic partnership between Huajian Medical and Renhe Pharmaceutical aims to establish the world's first specialized trading platform for over-the-counter (OTC) real-world assets (RWA), addressing a significant gap in the global market [1][2]. Group 1: Strategic Collaboration - The collaboration signifies a new phase in Huajian Medical's "ETHK" blockchain financial ecosystem strategy, marking the global debut of its innovative "ETHK Global RWA Exchange" business model [2]. - Renhe Pharmaceutical, as the president unit of the China OTC Association, plays a crucial role in industry policy discussions and standard-setting, leveraging its strong market position to lead the development of the OTC sector [1][2]. Group 2: Goals and Vision - The partnership reflects the commitment to create a transparent, efficient, and compliant digital trading platform for intangible assets and product rights in the OTC industry, ultimately serving the broader goal of enhancing the digital economy and national industrial upgrades [2]. - The collaboration is expected to generate significant synergies, driving strategic transformation and value reassessment for both companies, while ensuring the successful launch and operation of the OTC RWA exchange [3].